- 1、本文档共5页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Non-alcoholic fatty liver disease drug therapy research abroad
PAGE \* MERGEFORMAT 5
Non-alcoholic fatty liver disease drug therapy research abroad
[Abstract] Non-alcoholic fatty liver disease (NAFLD) is based primarily on pathophysiology of insulin resistance and oxidative stress, while the ease of insulin resistance, reduce oxidative stress, blood lipid and Hugan key strategies such as the treatment of NAFLD. Clinical trials confirmed that rosiglitazone, metformin, vitamin E and C, and so on atorvastatin treatment can ease the varying degrees of abnormal aminotransferase, fatty degeneration, inflammation and liver fibrosis. Good prospects for some drugs, but the lack of sufficiently strong randomized controlled trials, so there are not any special treatment of a drug recommended NAFLD.
[Keywords:] non-alcoholic fatty liver disease; drug therapy: rosiglitazone
[Abstract] Principal foundation of pathology and physiology in nonalcoholic fatty liver disease (NAFLD) is insulin resistance and oxidative stress,. And therapy strategy of NAFLD mainly includes: lessening insulin resistance, reducing oxidative stress, lipid-modulating and liver-protecting. Clinical trials confirm different level remission of transaminase disorders, steatosis, inflammation and liver fibrosis with treatment of rosiglitazone, metformin, atorvastatin Vitamins E and C etc.The development of many drugs lacks of adequately powered, randomized, controlled trials, so that it is currently difficult to make evidence-based recommendations on pharmacological treatment in NAFLD.
[Keywords:] Nonalcoholic fatty liver disease (NAFLD); Pharmacological treatment; Rosiglitazone
With the increased incidence of obesity and diabetes, NAFLD has become the focus of the medical profession. Researchers are constantly looking for the ideal drug treatment of NAFLD, this article will be abroad in recent years, some of drug treatment of fatty liver research information to make a profile.
A thiazolidinedione (Thiazolidinediones, TZDs)
Thiazolidinedione is a kind of in
您可能关注的文档
- Nitidine chloride in vivo anti-tumor effect and mechanism of.doc
- Nitrendipine and captopril on elderly patients with moderate to severe essential hypertension.doc
- Nitidine chloride induced apoptosis of hepatoma cells SMMC7721 Study.doc
- Nirvana Rebirth- An Inventory of Health Wine Marketing.doc
- Nitrendipine combined irbesartan hydrochlorothiazide systolic hypertension in elderly patients of 68 cases.doc
- Nitric oxide - Nitric oxide synthase system and fracture healing.doc
- Nitric oxide and Cataract Research.doc
- Nitrendipine tablets Irbesartan combined treatment of 50 hypertensive patients of clinical experience.doc
- Nitric oxide and deep hypothermic circulatory arrest after ischemia-reperfusion injury in the nervous system.doc
- Nitric oxide and inflammatory joint diseases.doc
文档评论(0)